GeneDx is trading at $61.80, up +10.06% in after-hours trading, though the reason for the rebound remains unclear.

  • GeneDx closed at $56.15 on October 23, 2026, after falling 16.37% during the regular session.
  • No clear after-hours catalyst was identified. The Seattle Children’s study was announced August 24, and the 27 ASHG abstracts were announced October 19—not in a new post-close release on October 23.
  • Broad market signals were mixed and do not clearly explain the rebound.